DILC (downregulated in liver cancer stem cells) functions as a tumor suppressor to inhibit LCSCs by preventing NF-κB binding, inhibiting IL-6 transcription and abolishing JAK2/STAT3 pathway activation. Here, NFKB1 is linked to neoplasm.